Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Vaneechoutte

Showing results (191-200 of 209) with videos related to

Pageof 21
Sort By:
The Journal of Antimicrobial Chemotherapy|October 14, 2017
Development and validation of an LC tandem MS assay for the quantification of β-lactam antibiotics in the sputum of cystic fibrosis patientsKatrien Forier, Virginie Van Heck, Mieke Carlier, et al.
Kidney International|April 23, 2020
Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney diseaseTessa Gryp, Kim De Paepe, Raymond Vanholder, et al.
Scientific Reports|February 24, 2016
Genomic and phenotypic characterization of the species Acinetobacter venetianusMarco Fondi, Isabel Maida, Elena Perrin, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 16, 2009
In vivo evaluation of the vaginal distribution and retention of a multi-particulate pellet formulationNele Poelvoorde, Hans Verstraelen, Rita Verhelst, et al.
The EMBO Journal|November 12, 2003
Beta-casein-derived peptides, produced by bacteria, stimulate cancer cell invasion and motilityMaria José Oliveira, Jozef Van Damme, Tineke Lauwaet, et al.
Plos One|January 4, 2013
Selection and characterization of a candidate therapeutic bacteriophage that lyses the Escherichia coli O104:H4 strain from the 2011 outbreak in GermanyMaia Merabishvili, Daniel De Vos, Gilbert Verbeken, et al.
Plos One|October 25, 2021
Prevalence, risk factors and adverse pregnancy outcomes of second trimester bacterial vaginosis among pregnant women in Bukavu, Democratic Republic of the CongoGuy Mulinganya, Annelies De Vulder, Ghislain Bisimwa, et al.
Scientific Reports|September 27, 2019
Development of a qPCR platform for quantification of the five bacteriophages within bacteriophage cocktail 2 (BFC2)Hans Duyvejonck, Maya Merabishvili, Jean-Paul Pirnay, et al.
Frontiers in Global Women'S Health|June 7, 2024
Second trimester vaginal <i>Candida</i> colonization among pregnant women attending antenatal care in Bukavu, Democratic Republic of the Congo: prevalence, clinical correlates, risk factors and pregnancy outcomesMulumeoderhwa Guy Mulinganya, Karen De Keyser, Irenge Jules Mongane, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 8, 2009
A pilot study evaluating the safety of vaginal administration of a multi-particulate pellet formulationGuido Lopes Dos Santos Santiago, Hans Verstraelen, Nele Poelvoorde, et al.
Pageof 21

Showing results (191-200 of 209) with videos related to

Sort By:
Pageof 21
The Journal of Antimicrobial Chemotherapy|October 14, 2017
Development and validation of an LC tandem MS assay for the quantification of β-lactam antibiotics in the sputum of cystic fibrosis patientsKatrien Forier, Virginie Van Heck, Mieke Carlier, et al.
Kidney International|April 23, 2020
Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney diseaseTessa Gryp, Kim De Paepe, Raymond Vanholder, et al.
Scientific Reports|February 24, 2016
Genomic and phenotypic characterization of the species Acinetobacter venetianusMarco Fondi, Isabel Maida, Elena Perrin, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 16, 2009
In vivo evaluation of the vaginal distribution and retention of a multi-particulate pellet formulationNele Poelvoorde, Hans Verstraelen, Rita Verhelst, et al.
The EMBO Journal|November 12, 2003
Beta-casein-derived peptides, produced by bacteria, stimulate cancer cell invasion and motilityMaria José Oliveira, Jozef Van Damme, Tineke Lauwaet, et al.
Plos One|January 4, 2013
Selection and characterization of a candidate therapeutic bacteriophage that lyses the Escherichia coli O104:H4 strain from the 2011 outbreak in GermanyMaia Merabishvili, Daniel De Vos, Gilbert Verbeken, et al.
Plos One|October 25, 2021
Prevalence, risk factors and adverse pregnancy outcomes of second trimester bacterial vaginosis among pregnant women in Bukavu, Democratic Republic of the CongoGuy Mulinganya, Annelies De Vulder, Ghislain Bisimwa, et al.
Scientific Reports|September 27, 2019
Development of a qPCR platform for quantification of the five bacteriophages within bacteriophage cocktail 2 (BFC2)Hans Duyvejonck, Maya Merabishvili, Jean-Paul Pirnay, et al.
Frontiers in Global Women'S Health|June 7, 2024
Second trimester vaginal <i>Candida</i> colonization among pregnant women attending antenatal care in Bukavu, Democratic Republic of the Congo: prevalence, clinical correlates, risk factors and pregnancy outcomesMulumeoderhwa Guy Mulinganya, Karen De Keyser, Irenge Jules Mongane, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 8, 2009
A pilot study evaluating the safety of vaginal administration of a multi-particulate pellet formulationGuido Lopes Dos Santos Santiago, Hans Verstraelen, Nele Poelvoorde, et al.
Pageof 21